Related Experiment Video
Updated: Jan 28, 2026

Production and Targeting of Monovalent Quantum Dots
Published on: October 23, 2014
Biotinylated-spiperone ligands for quantum dot labeling of the dopamine D2 receptor in live cell cultures
Ian D Tomlinson1, Oleg Kovtun1, Tiffany M Crescentini1
1Department of Chemistry, Vanderbilt University, Nashville, TN 37232, United States.
Abstract:
We have synthesized 3 analogs of the dopamine D2 receptor (D2 DR) antagonist spiperone that can be conjugated to streptavidin-coated quantum dots via a pegylated biotin derivative. Using fluorescent imaging we demonstrate that substitution on the spiro position is tolerated, whilst the length and rigidity of a spacer arm attached to spiperone is important in controlling specific labeling as well as minimizing nonspecific labeling to cells and the surface of cell culture dishes. The ligand with the most rigid linker IDT772 (4) had the best binding profile and had high specific binding to D2 DR expressing HEK-293T cells with low nonspecific binding to plates and HEK-293T cells that lacked the D2 DR.
Related Concept Videos
Quantum Numbers
The Quantum-Mechanical Model of an Atom
Ligand Binding and Linkage
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Internal Receptors
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...

